Stay updated on DS-8201a in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the DS-8201a in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS-8201a in HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.5.3' was added and the previous 'Revision: v3.5.2' was removed, signaling a small update to the page.
    Difference
    0.0%
    Check dated 2026-04-27T19:42:37.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T16:28:11.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Padua, Italy 35128 was updated to Padova, Italy 35128 in the locations list.
    Difference
    0.0%
    Check dated 2026-04-06T03:16:46.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131 as a study location and removed Napoli, Italy, 80131; page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T22:09:35.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T13:45:44.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Study status updated to Completed with a new completion date, replacing the previous Active, not recruiting status. Additional status-related dates were updated to reflect the completion timeline.
    Difference
    0.1%
    Check dated 2026-03-01T09:08:21.000Z thumbnail image

Stay in the know with updates to DS-8201a in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS-8201a in HER2+ Breast Cancer Clinical Trial page.